LifeTech Scientific

LifeTech Scientific Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of LifeTech Scientific (1302.HK) as of Nov 13, 2026 is 375.45 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 144.55 % — a change of 159.74% (higher).

Cash Conversion

375.45 %

YoY

159.74%

Last updated:

Cash Conversion Rate (OCF/Net Income) of LifeTech Scientific is 2025 375.45 % . Cash Conversion Rate (OCF/Net Income) of LifeTech Scientific was 2024 144.55 % . It decreases by 159.74% higher compared to the previous year.

The LifeTech Scientific Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
150.56 CNY
Jan 1, 2019
212.84 CNY
Jan 1, 2020
156.67 CNY
Jan 1, 2021
167.15 CNY
Jan 1, 2022
119.36 CNY
Jan 1, 2023
184.81 CNY
Jan 1, 2024
144.55 CNY
Jan 1, 2025
375.45 CNY
The LifeTech Scientific Cash Conversion history
YEARCash ConversionYoY
375.45 %+159.74%
144.55 %-21.79%
184.81 %+54.84%
119.36 %-28.59%
167.15 %+6.69%
156.67 %-26.39%
212.84 %+41.36%
150.56 %+58.90%
94.75 %+8.70%
87.16 %-98.58%
6,117.55 %-25,552.67%
-24.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LifeTech Scientific stock

Cash Conversion Rate (OCF/Net Income) of LifeTech Scientific is 375.45 % in 2025.

Cash Conversion Rate (OCF/Net Income) of LifeTech Scientific changed from 144.55 % to 375.45 %, representing a 159.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s LifeTech Scientific with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — LifeTech Scientific

All Key Metrics — LifeTech Scientific